Vid Leko
Impact in
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 5
- CAR-T cell therapy research 3
- Cancer Immunotherapy and Biomarkers 3
-
- Sirtuins and Resveratrol in Medicine 4
- Co-authors
- Steven A. Rosenberg (5 shared papers)Antonio Bedalov (4 shared papers)Julian A. Simon (3 shared papers)Uyen Lao (4 shared papers)Sumit Mahajan (2 shared papers)Taylor K. Loe (3 shared papers)Smitha Sripathy (3 shared papers)Jeff Posakony (1 shared paper)
- Journals
- Journal for ImmunoTherapy of Cancer (3 papers)Handbook of experimental pharmacology (1 paper)Cancer Cell (1 paper)The Journal of Immunology (1 paper)Journal of Medicinal Chemistry (1 paper)
- Partner nations
- United StatesSouth AfricaIsrael
In The Last Decade
Vid Leko
10 papers receiving 609 citations
Vid Leko's Hit Papers
Peers
Comparison fields: 5 of 70
- Geriatrics and Gerontology 114
- Immunology 252
- Oncology 285
- Physiology 37
- Molecular Biology 232
Countries citing papers authored by Vid Leko
This map shows the geographic impact of Vid Leko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vid Leko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vid Leko more than expected).
Fields of papers citing papers by Vid Leko
This network shows the impact of papers produced by Vid Leko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vid Leko. The network helps show where Vid Leko may publish in the future.
Co-authors
The 25 scholars most cited alongside Vid Leko, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Identifying and Targeting Human Tumor Antigens for T Cell-Based Immunotherapy of Solid Tumors Hit paper breakdown → | 2020 | 297 |
| 2 | 2014 | 110 | |
| 3 | 2017 | 49 | |
| 4 | 2012 | 46 | |
| 5 | 2019 | 41 | |
| 6 | 2013 | 30 | |
| 7 | 2011 | 26 | |
| 8 | 2021 | 15 | |
| 9 | 2023 | 2 | |
| 10 | 2018 | 2 | |
| 11 | 2025 | 0 |
About Vid Leko
Vid Leko is a scholar working on Oncology, Geriatrics and Gerontology, Immunology, Molecular Biology and Surgery, having authored 11 papers that have together received 618 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (4 papers), Sirtuins and Resveratrol in Medicine (4 papers), CAR-T cell therapy research (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Calcium signaling and nucleotide metabolism (2 papers), Genetics and Neurodevelopmental Disorders (2 papers), Autophagy in Disease and Therapy (2 papers) and Biochemical effects in animals (1 paper). The work is most often cited by research in Geriatrics and Gerontology (114 citations), Immunology (252 citations), Oncology (285 citations), Physiology (37 citations) and Molecular Biology (232 citations). Vid Leko has collaborated with scholars based in United States, South Africa and Israel. Frequent co-authors include Steven A. Rosenberg, Antonio Bedalov, Julian A. Simon, Uyen Lao, Sumit Mahajan, Taylor K. Loe, Smitha Sripathy, Jeff Posakony, Aaron D. Schuler and Michele Scian. Their work appears in journals such as Journal for ImmunoTherapy of Cancer, Handbook of experimental pharmacology, Cancer Cell, The Journal of Immunology and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.